Federal contract award
75N94025F00001
NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N94025D00003 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $4.8M |
| Current contract value | $4.8M |
| Potential contract value / ceiling | $17.2M |
| Start date | Jun 4, 2025 |
| Current end date | Jun 3, 2027 |
| Potential end date | Jun 3, 2032 |
| Latest award activity | Jun 3, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 3, 2026 | P00004 | $2.4M | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES: SEVERABLE |
| Jun 2, 2026 | P00003 | $0 | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES: SEVERABLE |
| Jan 23, 2026 | P00002 | $219.8K | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES: SEVERABLE |
| Sep 8, 2025 | P00001 | $279.6K | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND |
| Jun 4, 2025 | 0 | $1.9M | NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FORMS AND |
Estimated positioning window
Jun 3, 2031 – Dec 3, 2031
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2032-06-03 (2041 days from calculation)
- +5 points
- 21 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-06-03
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Oct 18, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Oct 11, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Oct 8, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Sep 20, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Sep 11, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Sep 4, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Aug 15, 2024 |
| OSINSKI, ELIZABETH J | Contact | eo43m@nih.gov 240-550-5028 | Source | Jan 3, 2024 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.